Table I.
Patient clinical demographics.
| Parameter | Glycerin group | Rhubarb group | P-value |
|---|---|---|---|
| Number of cases (n) | 56 | 56 | |
| Sex (male/female) | 46/10 | 43/13 | 0.483 |
| Age (years) | 43±16 | 45±15 | 0.673 |
| Class of intra-abdominal hypertension at admission, n (%) | |||
| I | 28 (50%) | 27 (48.2%) | 0.850 |
| II | 18 (32.1%) | 21 (37.5%) | 0.552 |
| III | 10 (17.9%) | 8 (14.3%) | 0.607 |
| Abdominal compartment syndrome at day 30, n (%) | 10 (17.9%) | 13 (23.2%) | 0.483 |
| Diagnosis, n (%) | |||
| Severe acute pancreatitis | 36 (64.3%) | 30 (53.6%) | 0.249 |
| Septic shock | 10 (17.9%) | 13 (23.2%) | 0.483 |
| Post-cardiopulmonary resuscitation | 5 (8.9%) | 10 (17.9%) | 0.165 |
| Bowel obstruction | 5 (8.9%) | 3 (5.4%) | 0.463 |
| Co-morbidities, n (%) | |||
| Hypertension | 11 (19.6%) | 6 (10.7%) | 0.188 |
| Diabetes | 7 (12.5%) | 9 (16.1%) | 0.589 |
| Hyperthyroidism | 2 (3.6%) | 0 (0.0%) | 0.154 |
| Schistosomal cirrhosis | 1 (1.8%) | 2 (3.6%) | 0.558 |
| Chronic obstructive pulmonary disease | 3 (5.4%) | 5 (8.9%) | 0.463 |
| No co-morbidities | 32 (57.1%) | 34 (60.7%) | 0.701 |
| Liver function | |||
| Alanine aminotransferase (U/l) | 89.60±25.81 | 95.18±27.23 | 0.268 |
| Aspartate aminotransferase (U/l) | 88.75±20.56 | 96.20±26.64 | 0.101 |
| Kidney function | |||
| Blood urea nitrogen (mmol/l) | 19.52±7.70 | 18.85±9.84 | 0.691 |
| Creatinine (µmol/l) | 151.39±45.93 | 139.96±27.44 | 0.113 |
| White blood cells (×109/l) | 17.06±8.51 | 16.35±7.37 | 0.636 |
| Body mass index (kg/m2) | 23.73±4.38 | 25.09±3.77 | 0.080 |